Back to results
US 10,765,760 B2Granted
Exon skipping oligomer conjugates for muscular dystrophy
AssigneeSarepta Therapeutics, Inc.
InventorsGunnar J. Hanson, Marco A. Passini, Frederick Joseph Schnell
Life of this patent
Estimating the term…
Abstract
Antisense oligomer conjugates complementary to a selected target site in the human dystrophin gene to induce exon 52 skipping are described.
Claims4
An antisense oligomer conjugate of Formula (IV):
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.